His abdomen distended and tender, the 6-year-old boy had gone without medical attention for four days. A ceiling had collapsed on top of him in the mayhem of Haiti’s devastating 7.1-magnitude earthquake, crushing his pelvis. Now, the boy lay in a makeshift infirmary at the U.S. Embassy in Port-au-Prince, which was being used by doctors to treat quake victims.
Henri Ronald Ford, M.D., a Haitian-born pediatric surgeon who flew to his homeland from Los Angeles to care for the injured, knew that if the youngster didn’t get immediate care, he would surely perish. So Ford and the boy were airlifted by helicopter to the USS Carl Vinson, anchored off the coast of Port-au-Prince to support disaster relief efforts. There, in the supercarrier’s medical facility, Ford saved the boy’s life.
Creed Pettit, a 9-year-old legally blind boy from Mount Dora, Florida, on March 22 became the first patient to undergo a landmark gene therapy surgery at Bascom Palmer Eye Institute, part of UHealth — the University of Miami Health System and the Miller School of Medicine. Creed was diagnosed at about age 2 with Leber congenital amaurosis, a blinding genetic disease caused by an RPE65 genetic mutation.
With the telltale beating of a single drum and a tap on the shoulder with an iron arrow, members of the Iron Arrow Honor Society this week renewed one of the U’s greatest spring traditions. Marching across the Coral Gables and medical campuses in a solemn procession, they bestowed a leading University of Miami honor on 22 lucky recipients — membership in the organization that recognizes students, faculty, staff, and alumni.
Susan Martin, senior division administrator for the Department of Medicine’s Katz Family Division of Nephrology and Hypertension, has received the Patriotic Employer Award from the Office of the Secretary of Defense – Employer Support of the Guard and Reserve. The award was presented on March 13 by Tom Green, area vice chair of the Employer Support of the Guard and Reserve.
A collaborative research team at the University of Miami Miller School of Medicine has developed a potential treatment strategy for Alport syndrome, a rare genetic condition characterized by kidney disease, hearing loss, and eye abnormalities. The researchers found that reducing osteopontin by genetic deletion can prevent kidney, vision, and hearing pathologies in the Alport mouse and could significantly extend its lifespan.
After three and a half years of medical school, a long residency application process, and an exciting, stressful week of waiting, the students under the tent in the Schoninger Research Quadrangle on Friday counted down the final 10 seconds to noon, dodged the confetti shooting through the air, and opened the envelopes that told them where they would spend the next several years of their lives.